Valuation: Zynex, Inc.

Market Cap 3.83M 3.35M 3.09M 2.86M 5.42M 365M 5.52M 36.99M 14.5M 179M 14.37M 14.06M 622M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 33.26M 30.67M 28.38M 53.87M 3.63B 54.77M 367M 144M 1.78B 143M 140M 6.17B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-49.95%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.82
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap.
03-26Issuer sale

Director

102,000 0.3357%
03-26Issuer sale

Director

95,000 0.3126%
03-26Issuer sale

Director

80,001 0.2633%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-97.70%-99.39% 1.69M
+2.86%+0.24%+24.97%+2.14% 190B
-0.86%-3.39%-22.07%+24.23% 147B
+0.40%-0.33%-56.30%-13.96% 66.6B
-2.47%-3.22%+18.32%+1.19% 53.92B
+0.38%-1.66%-27.47%-30.66% 43.57B
+3.50%+2.22%+10.13%+14.18% 36.45B
+2.44%-0.57%+8.00%+42.77% 36.15B
+1.27%-0.56%-18.57%-3.41% 29.69B
+0.03%-1.32%-14.32%-18.74% 29.42B
Average +1.41%-4.00%-17.50%-8.17% 63.24B
Weighted average by Cap. +1.09%-1.82%-4.40%+5.02%

Financials

2023 2024
Net sales 184M 161M 149M 138M 261M 17.59B 265M 1.78B 698M 8.64B 692M 677M 29.93B 192M 168M 155M 144M 273M 18.36B 277M 1.86B 728M 9.02B 722M 706M 31.23B
Net income 9.73M 8.51M 7.85M 7.26M 13.79M 929M 14.02M 94.02M 36.86M 456M 36.53M 35.74M 1.58B 2.99M 2.62M 2.42M 2.23M 4.24M 286M 4.31M 28.92M 11.34M 140M 11.24M 11M 486M
Net Debt 31.59M 27.63M 25.48M 23.58M 44.75M 3.02B 45.5M 305M 120M 1.48B 119M 116M 5.13B 34.19M 29.91M 27.58M 25.52M 48.44M 3.26B 49.25M 330M 129M 1.6B 128M 126M 5.55B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock